Fortune October 25, 2023
Richard Eisenberg

The Inflation Reduction Act will let Medicare negotiate prescription drug prices with manufacturers to combat soaring medication costs, which it’s never been allowed to do. So, the obvious question: If you’re on Medicare, will your drug costs come down?

The not-so-obvious answer: Possibly, though not imminently.

Medicare drug price negotiation “is a big deal,” says Andrea Ducas, vice president of health policy at the Center for American Progress, a progressive, nonpartisan policy institute.

Medicare drug price negotiation: ‘Pretty remarkable’

It’s actually enormously popular with bipartisan support, according to polls.

“Drug price negotiation actually puts America closer to sort of on par with where other countries are,” says Ducas. “It means that, for the first time, there will be an ability...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, CMS, Govt Agencies, Insurance, Medicare, Patient / Consumer, Pharma, Pharma / Biotech, Provider
Biden administration proposes Medicare coverage for weight loss drugs: 10 things to know
Proposed Coverage of Anti-Obesity Drugs in Medicare and Medicaid Would Expand Access to Millions of People with Obesity
Prior authorizations, pharmacy transparency, vertical integration all part of the Medicare 2026 rule
Medicare and Medicaid would cover Ozempic, Wegovy under new Biden rule
New Proposal Aims to Expand Medicaid and Medicare Coverage for Obesity Drugs

Share This Article